Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2025-06.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96 Risk factors for early-onset lung cancer in Korea: analysis of a nationally representative population-based cohort
Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Epidemiol Health > Volume 45; 2023 > Article
Original Article
 Risk factors for early-onset lung cancer in Korea: analysis of a nationally representative population-based cohort
Jihun Kang1orcid, Taeyun Kim2orcid, Kyung-Do Han3orcid, Jin-Hyung Jung4orcid, Su-Min Jeong5orcid, Yo Hwan Yeo6orcid, Kyuwon Jung7orcid, Hyun Lee8orcid, Jong Ho Cho9orcid, Dong Wook Shin10,11,12orcid
Epidemiol Health 2023;45:e2023101.
DOI: https://doi.org/10.4178/epih.e2023101
Published online: November 21, 2023

1Department of Family Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea

2Division of Pulmonology, Department of Internal Medicine, The Armed Forces Goyang Hospital, Goyang, Korea

3Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea

4Department of Medical Statistics, College of Medicine, The Catholic University of Korea, Seoul, Korea

5Department of Medicine, Seoul National University College of Medicine, Seoul, Korea

6Department of Family Medicine, Hallym University Sacred Heart Hospital, Dongtan, Korea

7Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, Goyang, Korea

8Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea

9Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

10Supportive Care Center, Samsung Comprehensive Cancer Center/Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

11Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea

12Center for Clinical Epidemiology, SAIHST, Sungkyunkwan University, Seoul, Korea

Correspondence: Dong Wook Shin, Supportive Care Center, Samsung Comprehensive Cancer Center/Department of Family Medicine, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea, E-mail: dwshin.md@gmail.com
Co-correspondence: Jong Ho Cho, Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea, E-mail: Jongho.cho@gmail.com
• Received: May 15, 2023   • Accepted: November 3, 2023

© 2023, Korean Society of Epidemiology

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 7,930 Views
  • 231 Download
  • 1 Web of Science
  • 1 Crossref
  • 1 Scopus
Full Article

Download PDF Download PDF

  • OBJECTIVES
    We examined the associations of socioeconomic factors, health behaviors, and comorbidities with early-onset lung cancer.
  • METHODS
    The study included 6,794,287 individuals aged 20–39 years who participated in a Korean national health check-up program from 2009 to 2012. During the follow-up period, 4,684 participants developed lung cancer. Multivariable Cox regression analysis was used to estimate the independent associations of potential risk factors with incident lung cancer.
  • RESULTS
    Older age (multivariable hazard ratio [mHR], 1.13; 95% confidence interval [CI], 1.12 to 1.14) and female sex (mHR, 1.62; 95% CI, 1.49 to 1.75) were associated with increased lung cancer risk. Current smoking was also associated with elevated risk (<10 pack-years: mHR, 1.12; 95% CI, 1.01 to 1.24; ≥10 pack-years: mHR, 1.30; 95% CI, 1.18 to 1.45), but past smoking was not. Although mild alcohol consumption (<10 g/day) was associated with lower lung cancer risk (mHR, 0.92; 95% CI, 0.86 to 0.99), heavier alcohol consumption (≥10 g/day) was not. Higher income (highest vs. lowest quartile: mHR, 0.86; 95% CI, 0.78 to 0.94), physical activity for at least 1,500 metabolic equivalent of task-min/wk (vs. non-exercisers: mHR, 0.83; 95% CI, 0.69 to 0.99) and obesity (vs. normal weight: mHR, 0.89; 95% CI, 0.83 to 0.96) were associated with lower lung cancer risk, whereas metabolic syndrome was associated with increased risk (mHR, 1.13; 95% CI, 1.03 to 1.24).
  • CONCLUSIONS
    In young adults, age, female sex, smoking, and metabolic syndrome were risk factors for early-onset lung cancer, while high income, physical activity, and obesity displayed protective effects.
  • Keywords: Lung cancer, Early-onset lung cancer, Risk factors, Health behavior, Korea
Lung cancer is the leading cause of cancer-specific death, and it ranks second in terms of cancer incidence in the United States and Korea [1,2]. Although tobacco smoking is commonly associated with the development of lung cancer, other risk factors such as advanced age [3–8], environmental and occupational exposure [9], and air pollution [10] contribute significantly to the incidence of this disease. However, given that lung cancer incidence sharply rises after the age of 50 years, most studies have focused on these risk factors in middle-aged to older patients. Consequently, a dearth of information is available on early-onset lung cancer, a topic that has garnered comparatively little research interest.
Assessing risk factors for early-onset lung cancer presents a challenge, given that incidence among young adults (those under 40 years of age) accounts for a mere 1.2% of total cases [7]. Several prior studies have consistently found that lung cancer in young adults is more common in female [6,7,11–14], primarily manifests as adenocarcinoma [6,7,11–13,15–17], and tends to present at an advanced stage [6,7,13,15] compared to lung cancer in older patients. However, these studies have primarily focused on comparing the clinical characteristics of young adults to those of older individuals [6,7,11–13,15–17], leaving a gap in the quantitative evaluation of risk factors associated with the development of lung cancer in the younger demographic.
A prior case-control study, matched for age and residence, proposed that heavy smoking, prolonged exposure to smoking, and a family history of lung cancer in first-degree relatives are risk factors for lung cancer in individuals under 45 years old [16]. While that study examined the relationships of tobacco smoking and other socioeconomic risk factors (such as education and marital status) with lung cancer among young adults, the low incidence of lung cancer cases in this age group impeded the ability to estimate other potential risk factors within a cohort design. These factors include alcohol consumption, physical activity, and cardiometabolic comorbidities. Furthermore, aside from studies of German (n=531) [16] and American samples using Surveillance, Epidemiology, and End Results (SEER) data (n=460,992) [6,7], most research on lung cancer in young adults has been based on data from single institutions. Consequently, nationwide data regarding risk factors associated with early lung cancer remain scarce.
In this context, we evaluated the risk factors of early-onset lung cancer, including socioeconomic elements, health behaviors, and comorbidities, using nationally representative population-based cohort data.
Data sources and study participants
For the present study, we utilized a dataset from the Korean National Health Insurance Service (KNHIS). The KNHIS is a universal healthcare system that covers 97% of the Korean population. The KNHIS dataset contains all reimbursement information, which includes diagnoses based on the International Classification of Diseases, 10th revision (ICD-10) as well as diagnostic and treatment procedures, prescriptions, and medical costs incurred. Furthermore, data are included on the age, sex, insurance premium (as determined by income status), and any disabilities of the beneficiaries.
The KNHIS administers a biannual nationwide health check-up program for all Korean employees aged 20 years and older. This program includes anthropometric measurements, health behavior questionnaires (covering topics such as smoking status, alcohol consumption, and physical activity), and past medical history, as well as biochemical tests. These components collectively form the KNHIS screening database [18,19].
Between 2009 and 2012, a total of 6,891,614 individuals aged 20–39 years took part in nationwide health examinations. Of these, 97,326 participants were excluded for the following reasons: any prior diagnosis of malignancy (n=23,035), missing data on covariates (n=71,611), and a diagnosis of lung cancer or death within 1 year of enrollment (n=2,681). Consequently, the analysis included a total of 6,794,287 individuals (Figure 1).
Outcome definition and follow-up
The primary outcome was defined as the incidence of lung cancer. Identification of lung cancer development was achieved using the lung cancer diagnosis code from the ICD-10 (C34), which was then matched to the critical illness registration program. This program requires a physician to submit a certificate of diagnosis for registration. Program beneficiaries can receive reductions in copayments of up to 95% for cancer diagnosis and treatment. As a result, these data offer a relatively high level of accuracy in cancer diagnosis [20] and have been utilized in various cancer epidemiology studies in Korea [8,21,22]. The study participants were monitored from the date of the first health examination (the index date) to the date of lung cancer diagnosis, the date of death from any other cause, or December 31, 2020, whichever occurred first.
Socioeconomic and health behavior factors
Trained medical assistants collected anthropometric measurements, while data about health behaviors were gathered through a self-administered questionnaire [19]. Healthcare professionals measured height (in meters) and weight (in kilograms) during the screening examination. Body mass index (BMI) was calculated in kg/m2 and further categorized into 4 groups (<18.5, 18.5–22.9, 23.0–24.9, and ≥25.0 kg/m2). Participants with a BMI of ≥25.0 kg/m2 were considered to have obesity [23]. Income was divided into 4 groups based on insurance fees, which were determined by household income. Smoking status included categories of non-smoker, former smoker with <10 pack-years, former smoker with ≥10 pack-years, current smoker with <10 pack-years, and current smoker with ≥10 pack-years [24]. Alcohol consumption was also categorized, with options of non-drinker, <10.0 g/day, 10.0–19.9 g/day, 20.0–29.9 g/day, and ≥30.0 g/day [21]. The International Physical Activity Questionnaire was employed to assess physical activity levels. Exercise of light, moderate, and vigorous intensity was assigned 2.9, 4.0, and 7.0 metabolic equivalents of task (METs), respectively, to calculate total energy expenditure levels. Physical activity was then divided to establish 5 groups according to METs: non-exerciser, <500, 500–999, 1,000–1,499, and ≥1,500 MET-min/wk [25].
Comorbidity factors
We collected information on comorbidities, such as disease codes and prescription records, over 1-year periods prior to the index date. Diabetes mellitus was identified by a diagnosis code record (E11.x–E14.x) in conjunction with antidiabetic medications or a fasting plasma glucose level of at least 126 mg/dL. Hypertension was defined through a combination of ICD-10 codes (I10–I13 and I15) and prescription records for antihypertensive agents, or a blood pressure reading of 140/90 mmHg or higher. Dyslipidemia was identified through a combination of ICD-10 codes (E78) and prescription records for lipid-lowering medications, or a total cholesterol level of 240 mg/dL or higher. Participants with metabolic syndrome were identified based on the criteria of the National Cholesterol Education Program’s Adult Treatment Panel III [26] and the abdominal obesity criteria of the Korean Society for the Study of Obesity [27]. A diagnosis of metabolic syndrome was made when 3 or more of the following were met: (1) a waist circumference of 90 cm or more in male and 85 cm or more in female; (2) a triglyceride level of 150 mg/dL or higher; (3) a high-density lipoprotein cholesterol level of less than 40 mg/dL in male and less than 50 mg/dL in female; (4) a blood pressure reading of 130/85 mmHg or higher, or current use of antihypertensive medications; and (5) a fasting glucose level of 100 mg/dL or higher, or current use of anti-diabetes medications.
Statistical analysis
We utilized chi-square tests to compare the baseline characteristics of male and female for categorical variables and Student t-tests for continuous variables. The incidence rate of lung cancer was calculated as the total number of incident cases divided by 1,000,000 person-years. Multivariable Cox regression analysis was employed to estimate the independent associations of each potential risk factor with the onset of lung cancer. Given that metabolic syndrome is a composite of cardiovascular risk factors, we analyzed the associations of individual cardiovascular determinants and metabolic syndrome with the development of lung cancer in the following manner: model 1 incorporated age, sex, income, smoking status, alcohol consumption, physical activity, obesity, diabetes, hypertension, and dyslipidemia, while model 2 included age, sex, income, smoking status, alcohol consumption, physical activity, and metabolic syndrome. We presented the values derived from model 1 as the primary results of our analyses. To estimate potential interactive effects of age and sex with other covariates, stratification analyses were performed.
Ethics statement
This study was approved by the Samsung Medical Center Institutional Review Board (2018-04-050). Due to the use of anonymized and de-identified data, the requirement for informed consent was waived.
Baseline characteristics of study participants
The median follow-up period for all participants was 9.62 years (interquartile range, 8.55–10.24), and the longest follow-up period was 11 years. The mean ages of participants with and without lung cancer were 33.6±4.5 years and 30.8±5.0 years, respectively (p<0.001). Those who developed lung cancer had a higher percentage of female compared to the control group (44.3 vs. 40.0%). Participants diagnosed with lung cancer exhibited higher rates of diabetes, hypertension, dyslipidemia, and metabolic syndrome than those in the control group. Furthermore, those who developed lung cancer were less physically active and consumed less alcohol compared to control participants (Table 1).
Risk factors of lung cancer in young adults

Socioeconomic factors

Table 2 presents the factors associated with the risk of early-onset lung cancer. The risk of lung cancer was found to escalate by a factor of 1.13 for each year of increase in participant age (multivariable hazard ratio [mHR], 1.13; 95% confidence interval [CI], 1.12 to 1.14). Female displayed a higher risk of lung cancer than male (mHR, 1.58; 95% CI, 1.46 to 1.72). The risk of lung cancer was found to be lower in the higher income groups compared to the lowest income group (Q1: mHR, 0.86; 95% CI, 0.78 to 0.94; Q2: mHR, 0.85; 95% CI, 0.78 to 0.93).

Health behavior factors

Lung cancer risk was observed to be positively associated with current smoking relative to non-smoking status. Current smokers with ≥10 pack-years exhibited an mHR of 1.30 (95% CI, 1.18 to 1.45), while current smokers with <10 pack-years had an mHR of 1.12 (95% CI, 1.01 to 1.24). In contrast, past smoking was not associated with increased risk. Participants who consumed less than 10 g/day of alcohol displayed a lower risk of developing lung cancer than non-drinkers (mHR, 0.92; 95% CI, 0.86 to 0.99); however, this protective effect was not observed in participants who consumed 10 g/day or more of alcohol. Physically active participants were less likely to be diagnosed with lung cancer than non-exercisers, with an mHR of 0.88 for 1,000–1,499 MET-min/wk (95% CI, 0.78 to 0.99) and an mHR of 0.83 for 1,500 MET-min/wk or more (95% CI, 0.69 to 0.99).

Comorbidity factors

Individuals with obesity (BMI ≥25.0 kg/m2) demonstrated a lower risk of lung cancer relative to the group with a normal BMI (18.5–22.9 kg/m2), with an HR of 0.89 (95% CI, 0.83 to 0.96). No increased or decreased lung cancer risk was observed in the underweight (BMI <18.5 kg/m2) or overweight groups (BMI 23.0–24.9 kg/m2). Diabetes mellitus (mHR, 1.08; 95% CI, 0.90 to 1.30), hypertension (mHR, 1.10; 95% CI, 0.99 to 1.22), and dyslipidemia (mHR, 1.05; 95% CI, 0.94 to 1.17) showed no association with lung cancer risk. However, in model 2, metabolic syndrome was associated with an elevated risk of lung cancer (mHR, 1.13; 95% CI, 1.03 to 1.24).
Risk stratification of lung cancer in young adults by age and sex
In age-stratified analyses, an interaction was observed between sex and age (pinteraction=0.047). For female in their 20s, female sex demonstrated a stronger association with lung cancer risk (mHR, 1.83; 95% CI, 1.53 to 2.17) than for female in their 30s (mHR, 1.49; 95% CI, 1.36 to 1.64; pinteraction=0.047). Significant interactive effects were noted for alcohol consumption (pinteraction=0.011) and BMI (pinteraction<0.001) with lung cancer risk in a sex-stratified analysis. Specifically, a protective association with mild drinking (<20 g/day) was found only in male (<10 g/day: mHR, 0.82; 95% CI, 0.74 to 0.91; ≥10 g/day: mHR, 0.87; 95% CI, 0.77 to 0.98), while being underweight was associated with elevated lung cancer risk in male only (mHR, 1.45; 95% CI, 1.16 to 1.81). Being overweight was associated with increased lung cancer risk only in female (mHR, 1.14; 95% CI, 1.01 to 1.30; Table 3).
This research represents the largest cohort study to date to evaluate the socioeconomic factors, health behaviors, and comorbidities associated with lung cancer risk in young adults under 40 years old. The risk of lung cancer was found to increase with age, and female were observed to have a higher risk of lung cancer than male, particularly among younger participants. Current smoking was linked to an elevated risk of lung cancer, whereas past smoking was not. Mild alcohol consumption, defined as less than 10 g/day, appeared to have a protective effect against lung cancer, but heavier alcohol consumption, defined as 10 g/day or more, did not. Higher income, physical activity, and obesity were all associated with a reduced risk of lung cancer. Conversely, metabolic syndrome was linked to an elevated risk of developing lung cancer.
Socioeconomic factors
In line with previous studies [3–8], advanced age was identified as a key determinant of lung cancer in young adults, with a 13% increase in risk for each additional year of age. The Liverpool Lung Project, a prospective cohort consisting of individuals aged 45 years and older, demonstrated that the risk of lung cancer rose by 4% for each 1-year increment in age (hazard ratio, 1.04; 95% CI, 1.02 to 1.06) [5]. Furthermore, the likelihood of lung cancer increased by 2% and 3% per year in American and Canadian cohorts, respectively (mean ages, 65.0 and 62.2 years, respectively) [28,29]. Consequently, while the absolute risk of lung cancer was lower in younger individuals compared to older people, the increase in relative risk per year was more pronounced in the younger population.
Among young adults, female exhibited a higher risk of lung cancer than male. This sex difference was especially pronounced in individuals under 30 years old. Many previous studies have noted that a higher proportion of female is a characteristic feature of early-onset lung cancer [6,7,11–13]. However, these studies have typically compared the risk of lung cancer in young individuals to that in older individuals, rather than comparing within an age group. A recent study utilizing SEER data from 2010 to 2014 reported that female under 50 years old displayed a higher incidence rate of lung cancer than male in the same age group (incidence rate ratio [IRR] for female vs. male, 1.13; 95% CI, 1.08 to 1.15) [14]. This difference was even more pronounced in cases of adenocarcinoma (IRRs for female vs. male, 1.29, 1.51). Given that adenocarcinoma is the predominant subtype at this age [6,7, 11–13,15–17] and is less influenced by smoking, the distinctive histopathological patterns of lung cancer could suggest an elevated risk of lung cancer in young female.
A negative social gradient was found to be associated with the risk of lung cancer. A previous meta-analysis revealed that the risk of lung cancer was 1.37 times higher (95% CI, 1.06 to 1.77) in the lowest compared to the highest income group [30]. Because income depends on occupational status, which is closely tied to health behaviors [31,32], low-income participants are more likely to smoke tobacco, consume unhealthy diets, be exposed to occupational carcinogens, and have limited access to health care. However, even after adjusting for smoking status, a negative social gradient in relation to lung cancer risk persisted, suggesting that disparities in socioeconomic status continue to independently contribute to lung cancer development. Moreover, sex-stratified analyses revealed stronger associations in male than in female participants, although these were only marginally significant. This suggests that occupational exposure (for example, factory work) may play a role in the link between income status and lung cancer risk. However, our data regarding job classification and occupational exposure are limited, and further studies are required.
Health behavior factors
Smoking is a well-established risk factor for lung cancer [33]. In the present study, we found that tobacco exposure significantly contributed to the development of lung cancer in the young participants. Specifically, current smokers exhibited a risk elevated by 10–30%, depending on the pack-years of smoking. However, the effect size of smoking on lung cancer incidence was relatively small in young adults compared to older individuals. A Korean study involving participants aged 40 years and above found that those who smoked 10–20 pack-years had a 1.51-fold (95% CI, 1.22 to 1.88) higher risk of lung cancer compared to non-smokers, with the risk escalating with increased pack-years [8]. In terms of the contribution of smoking to lung cancer risk, the strength of this association was less pronounced in our study, which focused on a younger population (HR, 1.30; 95% CI, 1.18 to 1.45). The duration and amount of smoking are linked to lung cancer risk in a dose-dependent manner [16,33], and young adults inherently tend to have a shorter exposure period to smoking than older adults. This results in a smaller contribution of smoking to lung cancer risk.
In young adults who were former smokers, no significant increase was observed in the risk of lung cancer. This aligns with the findings of a previous study of British doctors, which suggested that ceasing to smoke in one’s 30s could eliminate over 90% of the risk associated with smoking [34]. Although a decade of follow-up is insufficient to estimate the lifelong risk reduction of early smoking cessation on lung cancer, our findings nonetheless underscore the importance of promoting early tobacco cessation to prevent an increased risk of lung cancer.
Our findings also suggest that moderate drinkers, specifically those who consume less than 10 g of alcohol per day, have a marginally reduced risk of lung cancer compared to non-drinkers. Individuals in good health may tend to consume alcohol in moderation, while those with medical issues often decrease their alcohol intake or cease consumption altogether. This correlation between health status and patterns of alcohol consumption could potentially account for the lower risk of lung cancer observed among mild alcohol drinkers [35].
Participants who were physically active demonstrated a reduced risk of lung cancer compared to those who were physically inactive. This finding aligns with a study conducted in the United States, which reported a reverse correlation between physical activity and lung cancer risk in participants aged 54–62 years [36]. Similarly, studies from the Female’s Health Initiative and Harvard University, involving participants aged 50–79 years and 39–88 years, respectively, found that physical activity was linked to a lower incidence of lung cancer in a dose-dependent manner [37,38]. Our study suggests that the protective correlation between physical activity and lung cancer incidence is not limited to older individuals, but also applies to younger people. From a biological perspective, it is reasonable to propose that physical activity may have a protective effect against lung cancer, as physical activity and exercise are known to enhance immune function [39]. Furthermore, increased pulmonary ventilation and perfusion could reduce the interactions between potential carcinogenic agents and the airways, thereby decreasing the incidence of lung cancer [40].
Comorbidity factors
Obesity was found to have an inverse association with lung cancer risk. The literature indicates an intriguing relationship between obesity and the risk of incident lung cancer. While most previous cohort studies have suggested that a higher BMI is associated with a decreased risk of lung cancer [41,42], waist circumference, which is a proxy of central obesity, has been positively correlated with lung cancer risk [41]. Several hypotheses have been proposed to explain this paradoxical effect of obesity on the development of lung cancer. For instance, BMI has been inversely correlated with the level of oxidative DNA damage and carcinogen-DNA adducts in smokers, suggesting that a leaner physique may increase susceptibility to the development of smoking-related cancers [43,44]. Furthermore, a genetic variant of the FTO gene (rs9939609), which is associated with greater body weight, has been associated with lower lung cancer risk [45].
Notably, our study found an increased risk of lung cancer associated with metabolic syndrome, a finding that aligns with a recent cohort study. That study reported a linear association between the number of metabolic components and the development of lung cancer [24]. The degree of association between metabolic syndrome and lung cancer risk in our study was comparable to the overall effect previously found [24]. While the underlying mechanism remains unclear, insulin resistance and chronic inflammation are potential factors contributing to the heightened lung cancer risk observed in metabolic syndrome. Insulin resistance often leads to elevated serum insulin, which can enhance the effects of insulin-like growth factor 1. This factor may function in lung cancer development by promoting cell proliferation and angiogenesis [46]. Furthermore, chronic inflammation, caused by proinflammatory cytokines derived from adipocytes, could contribute to lung cancer development. This inflammation could inhibit DNA repair and create a microenvironment of genomic instability, leading to tumorigenesis [47].
In the present study, cardiometabolic comorbidities, such as hypertension, diabetes mellitus, and dyslipidemia, were not significant factors associated with lung cancer risk. However, hypertension was associated with an increased risk of lung cancer among male and individuals in their 30s. This finding aligns with a Finnish study that identified high blood pressure as an independent risk factor for incident lung cancer in male smokers with hypertension [48]. We also found hypertension to be a significant risk factor in young male, although we observed no significant or marginal sex difference (pinteraction=0.07). However, a meta-analysis of randomized control studies has reported that antihypertensive medications did not significantly increase cancer risk [49]. Given the limited data and research on this topic, the reason for this positive association being observed only in male individuals remains unclear.
This study does present several limitations. First, the lack of histopathologic information in the KNHIS health check-ups and insurance claim data prevented us from classifying the subtypes of lung cancer. As a result, we were unable to investigate the differential risk factors associated with various histologic types of lung cancer. According to the national cancer registry data from Korea, adenocarcinoma accounted for 80% of all lung cancer cases in younger individuals [20] (Supplementary Material 1). This proportion exceeded the rates reported in other countries with comparable age groups, which range from 40% to 60% [6,7,16,17]. Second, we did not consider several factors that significantly contribute to the development of lung cancer at early ages, such as a family history of lung cancer, air pollution, and genetic mutations or polymorphisms. Third, our study sample had an over-representation of male participants (60% compared to 51.6% in census data). This discrepancy occurred because the study enrolled participants from a health screening program that was exclusively available to employees during the study period. Despite these limitations, we identified risk factors associated with lung cancer risk in a nationally representative sample of young adults. These risk factors could potentially serve as useful variables in risk stratification strategies for young individuals at high risk of lung cancer. This includes those with a positive family history of lung cancer, those exposed to occupational carcinogens, and those living in areas with high indoor radon levels.
In conclusion, the present study indicates that in young adults, age, female sex, smoking, and metabolic syndrome are risk factors for lung cancer, while higher income, physical activity, and obesity displayed inverse associations with lung cancer risk.
This study was performed using the National Health Insurance System database. However, the findings do not necessarily reflect the views of the National Health Insurance Corporation. Restrictions apply to the availability of these data, which were used under license for this study.
Supplementary material is available at http://www.e-epih.org/.
epih-45-e2023101-Supplementary-1.docx

CONFLICT OF INTEREST

The authors have no conflicts of interest to declare for this study.

FUNDING

None.

AUTHOR CONTRIBUTIONS

Conceptualization: Kang J, Cho JH, Shin DW. Data curation: Han KD, Jung JH. Formal analysis: Han KD, Jung JH. Funding acquisition: None. Methodology: Kang J, Han KD, Jung JH, Cho JH, Shin DW. Visualization: Kang J, Han KD, Jung JH. Writing – original draft: Kang J, Cho JH, Shin DW. writing – review & editing: Kang J, Kim T, Han KD, Jung JH, Jeong SM, Yeo YH, Jung K, Lee H, Cho JH, Shin DW.

None.
Figure 1
Flow diagram of study participants.
epih-45-e2023101f1.jpg
Table 1.
Baseline characteristics of study participants
Characteristics Early-onset lung cancer incidence
 p-value1
Yes (n=4,684) No (n=6,789,603)
Age, mean±SD (yr) 33.6±4.5 30.8±5.0 <0.001
 20-29 964 (20.6) 2,891,243 (42.6) <0.001
 30-39 3,720 (79.4) 3,898,360 (57.4)
Sex <0.001
 Male 2,611 (55.7) 4,075,033 (60.0)
 Female 2,073 (44.3) 2,714,570 (40.0)
Income <0.001
 Q1 (highest) 1,031 (22.0) 1,688,522 (24.9)
 Q2 1,188 (25.4) 2,096,156 (30.9)
 Q3 1,482 (31.6) 2,003,758 (29.5)
 Q4 (lowest) 983 (21.0) 1,001,167 (14.8)
Smoking status (pack-yr) <0.001
 Non-smoker 2,585 (55.2) 3,716,798 (54.7)
 Former smoker with <10 492 (10.5) 700,679 (10.3)
 Former smoker with ≥10 183 (3.91) 349,020 (5.1)
 Current smoker with <10 742 (15.8) 1,210,833 (17.8)
 Current smoker with ≥10 682 (14.6) 812,273 (12.0)
Alcohol consumption (g/day) <0.001
 Non-drinker 1,962 (41.9) 2,562,059 (37.7)
 <10.0 1,351 (28.8) 2,155,232 (31.7)
 10.0-19.9 636 (13.6) 991,387 (14.6)
 20.0-29.9 327 (7.0) 487,563 (7.2)
 ≥30.0 408 (8.7) 593,362 (8.7)
Physical activity (MET-min/wk) <0.001
 Non-exerciser 1,049 (22.4) 1,382,689 (20.4)
 <500 1,820 (38.9) 2,529,402 (37.3)
 500-999 1,324 (28.3) 2,032,503 (28.0)
 1,000-1,499 367 (7.8) 614,699 (9.1)
 ≥1,500 124 (2.7) 230,310 (3.4)
BMI (kg/m2) 0.222
 <18.5 329 (7.0) 505,714 (7.5)
 18.5-22.9 2,181 (46.6) 3,164,194 (46.6)
 23.0-24.9 958 (20.5) 1,317,337 (19.4)
 ≥25.0 1,216 (26.0) 1,802,358 (26.6)
Diabetes 121 (2.6) 128,949 (1.9) <0.001
Hypertension 426 (9.1) 502,257 (7.4) <0.001
Dyslipidemia 391 (8.4) 459,750 (6.8) <0.001
Metabolic syndrome 604 (12.9) 717,332 (10.6) <0.001

Values are presented as number (%).

SD, standard deviation; Q, quartile; MET, metabolic equivalents of task; BMI, body mass index.

1 Categorical variables were compared using the chi-square test, and continuous variables were compared using the Student t-test.

Table 2.
Risk of lung cancer in young adults
Variables n Event (n) Duration (PY) Incidence rate (per 100,000 PY) Univariable Model 11 Model 22
Age
 Per 1 yr - - - - 1.13 (1.12, 1.13) 1.13 (1.12, 1.14) 1.13 (1.12, 1.14)
Sex
 Male 4,077,644 2,611 38,427,542.6 6.78 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Female 2,716,643 2,073 25,134,725.4 8.25 1.23 (1.16, 1.31) 1.58 (1.46, 1.72) 1.62 (1.49, 1.75)
Income
 Q1 (highest) 1,689,553 1,031 15,536,470.2 6.64 0.66 (0.61, 0.72) 0.86 (0.78, 0.94) 0.86 (0.78, 0.94)
 Q2 2,097,344 1,188 19,459,692.7 6.11 0.61 (0.56, 0.66) 0.85 (0.78, 0.93) 0.85 (0.78, 0.93)
 Q3 2,005,240 1,482 18,998,286.8 7.80 0.76 (0.70, 0.83) 0.92 (0.85, 1.00) 0.92 (0.85, 1.00)
 Q4 (lowest) 1,002,150 983 9,567,818.3 10.27 1.00 (reference) 1.00 (reference) 1.00 (reference)
Smoking status (pack-yr)
 Non-smoker 3,719,383 2,585 34,596,750.0 7.47 1.00 (reference) 1.00 (reference) 1.00 (reference)
 Former smoker with <10 701,171 492 6,657,102.4 7.39 0.97 (0.88, 1.07) 1.01 (0.91, 1.13) 1.01 (0.91, 1.13)
 Former smoker with ≥10 349,203 183 3,243,215.8 5.64 0.76 (0.65, 0.88) 0.95 (0.81, 1.11) 0.95 (0.81, 1.11)
 Current smoker with <10 1,211,575 742 11,376,708.6 6.52 0.87 (0.80, 0.94) 1.12 (1.01, 1.24) 1.12 (1.01, 1.24)
 Current smoker with ≥10 812,955 682 7,688,491.1 8.87 1.17 (1.08, 1.27) 1.30 (1.18, 1.45) 1.29 (1.16, 1.44)
Alcohol consumption (g/day)
 Non-drinker 2,564,021 1,962 23,927,308.5 8.20 1.00 (reference) 1.00 (reference) 1.00 (reference)
 <10.0 2,156,583 1,351 20,129,448.0 6.71 0.82 (0.76, 0.88) 0.92 (0.86, 0.99) 0.93 (0.86, 0.99)
 10.0-19.9 992,023 636 9,339,152.5 6.81 0.83 (0.75, 0.90) 0.95 (0.87, 1.05) 0.95 (0.87, 1.05)
 20.0-29.9 487,890 327 4,592,433.7 7.12 0.86 (0.77, 0.97) 0.96 (0.85, 1.09) 0.96 (0.85, 1.09)
 ≥30.0 593,770 408 5,573,925.3 7.32 0.89 (0.80, 0.99) 1.01 (0.90, 1.13) 1.00 (0.89, 1.13)
Physical activity (MET-min/wk)
 Non-exerciser 1,383,738 1,049 12,881,555.6 8.14 1.00 (reference) 1.00 (reference) 1.00 (reference)
 <500 2,531,222 1,820 23,740,196.2 7.67 0.94 (0.87, 1.00) 0.97 (0.90, 1.04) 0.97 (0.90, 1.04)
 500-999 2,033,827 1,324 19,014,025.4 6.96 0.85 (0.79, 0.92) 0.95 (0.88, 1.04) 0.95 (0.88, 1.03)
 1,000-1,499 615,066 367 5,767,558.8 6.36 0.78 (0.69, 0.88) 0.88 (0.78, 0.99) 0.88 (0.78, 0.99)
 ≥1,500 230,434 124 2,158,931.9 5.74 0.70 (0.58, 0.85) 0.83 (0.69, 0.99) 0.82 (0.68, 0.99)
BMI (kg/m2)
 <18.5 506,043 329 4,696,833.9 7.01 0.95 (0.85, 1.07) 1.07 (0.95, 1.20) 1.07 (0.95, 1.20)
 18.5-22.9 3,166,375 2,181 29,568,682.4 7.38 1.00 (reference) 1.00 (reference) 1.00 (reference)
 23.0-24.9 1,318,295 958 12,394,350.4 7.73 1.04 (0.97, 1.13) 1.00 (0.92, 1.08) 1.00 (0.92, 1.08)
 ≥25.0 1,803,574 1,216 16,902,391.0 7.19 0.97 (0.91, 1.04) 0.89 (0.83, 0.96) 0.88 (0.81, 0.95)
Diabetes
 No 6,291,604 4,563 62,354,799.9 7.32 1.00 (reference) 1.00 (reference) -
 Yes 502,683 121 1,207,468.1 10.02 1.37 (1.14, 1.64) 1.08 (0.90, 1.30) -
Hypertension
 No 6,334,146 4,258 58,837,673.6 7.24 1.00 (reference) 1.00 (reference) -
 Yes 460,141 426 4,724,594.4 9.02 1.24 (1.12, 1.37) 1.10 (0.99, 1.22) -
Dyslipidemia
 No 6,076,351 4,293 59,230,914.6 7.25 1.00 (reference) 1.00 (reference) -
 Yes 717,936 391 4,331,353.4 9.03 1.24 (1.12, 1.37) 1.05 (0.94, 1.17) -
Metabolic syndrome
 No 4,077,644 4,080 56,810,731.3 7.18 1.00 (reference) - 1.00 (reference)
 Yes 2,716,643 604 6,751,536.7 8.95 1.24 (1.14, 1.35) - 1.13 (1.03, 1.24)

Values are presented as hazard ratio (95% confidence interval).

PY, person-years; Q, quartile; MET, metabolic equivalents of task; BMI, body mass index.

1 Model 1 was adjusted for age, sex, income, smoking status, alcohol consumption, physical activity, obesity, diabetes, hypertension, and dyslipidemia.

2 Model 2 was adjusted for age, sex, income, smoking status, alcohol consumption, physical activity, and metabolic syndrome.

Table 3.
Stratification of lung cancer risk by age and sex in young adults1
Variables N Age (yr)
 Sex
Event (n) 20-29 Event (n) 30-39 pinteraction Event (n) Male Event (n) Female pinteraction
Age
 Per 1 yr 1.13 (1.12, 1.14) 1.12 (1.11, 1.13) 0.204
Sex
 Male 4,077,644 398 1.00 (reference) 2,213 1.00 (reference) 0.047 - -
 Female 2,716,643 566 1.83 (1.53, 2.17) 1,507 1.49 (1.36, 1.64) - -
Income 0.817 0.070
 Q1 (highest) 1,689,553 260 0.84 (0.66, 1.08) 771 0.87 (0.79, 0.96) 365 0.76 (0.67, 0.87) 666 1.00 (0.87, 1.16)
 Q2 2,097,344 359 0.82 (0.65, 1.05) 829 0.86 (0.78, 0.95) 601 0.81 (0.73, 0.91) 587 0.94 (0.82, 1.09)
 Q3 2,005,240 265 0.95 (0.73, 1.21) 1,217 0.91 (0.83, 0.99) 931 0.88 (0.80, 0.98) 551 1.01 (0.87, 1.17)
 Q4 (lowest) 1,002,150 80 1.00 (reference) 903 1.00 (reference) 714 1.00 (reference) 269 1.00 (reference)
Smoking status (pack-yr) 0.124 0.530
 Non-smoker 3,719,383 633 1.00 (reference) 1,952 1.00 (reference) 682 1.00 (reference) 1,903 1.00 (reference)
 Former smoker with <10 701,171 77 1.36 (1.06, 1.75) 415 0.95 (0.85, 1.08) 424 1.00 (0.88, 1.13) 68 1.07 (0.84, 1.37)
 Former smoker with ≥10 349,203 43 0.99 (0.72, 1.37) 140 0.93 (0.78, 1.11) 137 0.97 (0.81, 1.17) 46 0.89 (0.66, 1.20)
 Current smoker with <10 1,211,575 143 1.19 (0.95, 1.48) 599 1.10 (0.98, 1.23) 691 1.11 (1.00, 1.24) 51 1.33 (0.99, 1.76)
 Current smoker with ≥10 812,955 68 1.23 (0.92, 1.64) 614 1.29 (1.15, 1.44) 677 1.30 (1.16, 1.45) 5 0.80 (0.33, 1.92)
Alcohol consumption (g/day) 0.088 0.011
 Non-drinker 2,564,021 382 1.00 (reference) 1,580 1.00 (reference) 735 1.00 (reference) 1,227 1.00 (reference)
 <10.0 2,156,583 333 0.99 (0.85, 1.15) 1,018 0.90 (0.83, 0.98) 706 0.82 (0.74, 0.91) 645 1.02 (0.92, 1.12)
 10.0-19.9 992,023 113 0.86 (0.69, 1.07) 523 0.97 (0.87, 1.08) 500 0.87 (0.77, 0.98) 136 1.08 (0.90, 1.30)
 20.0-29.9 487,890 71 1.20 (0.92, 1.56) 256 0.91 (0.79, 1.05) 294 0.92 (0.80, 1.06) 33 0.79 (0.56, 1.12)
 ≥30.0 593,770 65 0.89 (0.67, 1.18) 343 1.03 (0.90, 1.17) 376 0.96 (0.84, 1.09) 32 0.90 (0.62, 1.28)
Physical activity (MET-min/wk) 0.763 0.147
 Non-exerciser 1,383,738 183 1.00 (reference) 866 1.00 (reference) 506 1.00 (reference) 543 1.00 (reference)
 <500 2,531,222 369 1.01 (0.84, 1.20) 1,451 0.96 (0.88, 1.04) 965 1.03 (0.92, 1.14) 855 0.91 (0.82, 1.02)
 500-999 2,033,827 298 0.98 (0.81, 1.18) 1,026 0.95 (0.87, 1.04) 804 1.03 (0.92, 1.15) 520 0.88 (0.78, 0.99)
 1,000-1,499 615,066 89 1.03 (0.80, 1.33) 278 0.85 (0.74, 0.97) 252 0.98 (0.84, 1.14) 115 0.76 (0.62, 0.93)
 ≥1,500 230,434 25 0.81 (0.54, 1.24) 99 0.83 (0.68, 1.03) 84 0.83 (0.66, 1.05) 40 0.88 (0.64, 1.22)
BMI (kg/m2) 0.312 <0.001
 <18.5 506,043 112 0.93 (0.76, 1.14) 217 1.13 (0.98, 1.31) 84 1.45 (1.16, 1.81) 245 0.97 (0.84, 1.11)
 18.5-22.9 3,166,375 538 1.00 (reference) 1,643 1.00 (reference) 907 1.00 (reference) 1,274 1.00 (reference)
 23.0-24.9 1,318,295 161 1.06 (0.88, 1.27) 797 0.99 (0.90, 1.08) 644 0.93 (0.84, 1.03) 314 1.14 (1.01, 1.30)
 ≥25.0 1,803,574 153 0.87 (0.72, 1.05) 1,063 0.90 (0.83, 0.98) 976 0.88 (0.80, 0.97) 240 0.89 (0.77, 1.02)
Diabetes 0.235 0.067
 No 6,291,604 959 1.00 (reference) 3,604 1.00 (reference) 2,507 1.00 (reference) 2,056 1.00 (reference)
 Yes 502,683 5 0.64 (0.27, 1.54) 116 1.10 (0.91, 1.33) 104 1.17 (0.96, 1.43) 17 0.72 (0.45, 1.17)
Hypertension 0.196 0.064
 No 6,334,146 932 1.00 (reference) 3,326 1.00 (reference) 2,242 1.00 (reference) 2,016 1.00 (reference)
 Yes 460,141 32 0.88 (0.61, 1.26) 394 1.12 (1.01, 1.25) 369 1.15 (1.02, 1.29) 57 0.88 (0.67, 1.17)
Dyslipidemia 0.923 0.787
 No 6,076,351 928 1.00 (reference) 3,365 1.00 (reference) 2,309 1.00 (reference) 1,984 1.00 (reference)
 Yes 717,936 36 1.04 (0.74, 1.45) 355 1.05 (0.94, 1.17) 302 1.06 (0.94, 1.20) 89 1.03 (0.83, 1.27)

Values are presented as hazard ratio (95% confidence interval).

Q, quartile; MET, metabolic equivalents of task; BMI, body mass index.

1 The stratified analysis was adjusted for age, sex, income, smoking status, alcohol consumption, physical activity, obesity, diabetes, hypertension, and dyslipidemia.

  • 1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73:17-48.ArticlePubMedPDF
  • 2. Kang MJ, Jung KW, Bang SH, Choi SH, Park EH, Yun EH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020. Cancer Res Treat 2023;55:385-399.ArticlePubMedPMCPDF
  • 3. Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011;103:1058-1068.ArticlePubMedPMC
  • 4. Hoggart C, Brennan P, Tjonneland A, Vogel U, Overvad K, Østergaard JN, et al. A risk model for lung cancer incidence. Cancer Prev Res (Phila) 2012;5:834-846.ArticlePubMedPMCPDF
  • 5. Marcus MW, Chen Y, Raji OY, Duffy SW, Field JK. LLPi: Liverpool lung project risk prediction model for lung cancer incidence. Cancer Prev Res (Phila) 2015;8:570-575.ArticlePubMedPDF
  • 6. Thomas A, Chen Y, Yu T, Jakopovic M, Giaccone G. Trends and characteristics of young non-small cell lung cancer patients in the United States. Front Oncol 2015;5:113.ArticlePubMedPMC
  • 7. Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J, et al. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis. J Thorac Oncol 2010;5:23-28.ArticlePubMed
  • 8. Yeo Y, Shin DW, Han K, Park SH, Jeon KH, Lee J, et al. Individual 5-year lung cancer risk prediction model in Korea using a nationwide representative database. Cancers (Basel) 2021;13:3496.ArticlePubMedPMC
  • 9. Ilar A, Plato N, Lewné M, Pershagen G, Gustavsson P. Occupational exposure to diesel motor exhaust and risk of lung cancer by histological subtype: a population-based case-control study in Swedish men. Eur J Epidemiol 2017;32:711-719.ArticlePubMedPMCPDF
  • 10. Raaschou-Nielsen O, Andersen ZJ, Beelen R, Samoli E, Stafoggia M, Weinmayr G, et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 2013;14:813-822.PubMed
  • 11. Radzikowska E, Roszkowski K, Głaz P. Lung cancer in patients under 50 years old. Lung Cancer 2001;33:203-211.ArticlePubMed
  • 12. Sekine I, Nishiwaki Y, Yokose T, Nagai K, Suzuki K, Kodama T. Young lung cancer patients in Japan: different characteristics between the sexes. Ann Thorac Surg 1999;67:1451-1455.ArticlePubMed
  • 13. Shi J, Li D, Liang D, He Y. Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China. Sci Rep 2021;11:6817.ArticlePubMedPMCPDF
  • 14. Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med 2018;378:1999-2009.ArticlePubMedPMC
  • 15. Liu B, Quan X, Xu C, Lv J, Li C, Dong L, et al. Lung cancer in young adults aged 35 years or younger: a full-scale analysis and review. J Cancer 2019;10:3553-3559.ArticlePubMedPMC
  • 16. Kreuzer M, Kreienbrock L, Gerken M, Heinrich J, Bruske-Hohlfeld I, Muller KM, et al. Risk factors for lung cancer in young adults. Am J Epidemiol 1998;147:1028-1037.ArticlePubMed
  • 17. Skarin AT, Herbst RS, Leong TL, Bailey A, Sugarbaker D. Lung cancer in patients under age 40. Lung Cancer 2001;32:255-264.ArticlePubMed
  • 18. Seong SC, Kim YY, Khang YH, Park JH, Kang HJ, Lee H, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 2017;46:799-800.PubMed
  • 19. Shin DW, Cho J, Park JH, Cho B. National General Health Screening Program in Korea: history, current status, and future direction. Precis Futur Med 2022;6:9-31.ArticlePDF
  • 20. Yang MS, Park M, Back JH, Lee GH, Shin JH, Kim K, et al. Validation of cancer diagnosis based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea. Cancer Res Treat 2022;54:352-361.ArticlePubMedPMCPDF
  • 21. Yoo JE, Shin DW, Han K, Kim D, Jeong SM, Koo HY, et al. Association of the frequency and quantity of alcohol consumption with gastrointestinal cancer. JAMA Netw Open 2021;4:e2120382.ArticlePubMedPMC
  • 22. Kang J, Jeong SM, Shin DW, Cho M, Cho JH, Kim J. The associations of aspirin, statins, and metformin with lung cancer risk and related mortality: a time-dependent analysis of population-based nationally representative data. J Thorac Oncol 2021;16:76-88.ArticlePubMed
  • 23. Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, et al. The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 2003;45:335-343.ArticlePubMedPDF
  • 24. Sin S, Lee CH, Choi SM, Han KD, Lee J. Metabolic syndrome and risk of lung cancer: an analysis of Korean National Health Insurance Corporation Database. J Clin Endocrinol Metab 2020;105:dgaa596.ArticlePubMedPDF
  • 25. Jeong SW, Kim SH, Kang SH, Kim HJ, Yoon CH, Youn TJ, et al. Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J 2019;40:3547-3555.ArticlePubMedPMCPDF
  • 26. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.ArticlePubMed
  • 27. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes 2006;15:1-9. (Korean).
  • 28. Winkler Wille MM, van Riel SJ, Saghir Z, Dirksen A, Pedersen JH, Jacobs C, et al. Predictive accuracy of the PanCan lung cancer risk prediction model-external validation based on CT from the Danish lung cancer screening trial. Eur Radiol 2015;25:3093-3099.ArticlePubMedPDF
  • 29. de Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, et al. Lung cancer in patients with chronic obstructive pulmonary disease--incidence and predicting factors. Am J Respir Crit Care Med 2011;184:913-919.ArticlePubMed
  • 30. Sidorchuk A, Agardh EE, Aremu O, Hallqvist J, Allebeck P, Moradi T. Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control 2009;20:459-471.ArticlePubMedPDF
  • 31. Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci 2012;1248:107-123.ArticlePubMed
  • 32. Potter JD. Diet and cancer: possible explanations for the higher risk of cancer in the poor. IARC Sci Publ; 1997. p 265-283.
  • 33. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002;3:461-469.ArticlePubMed
  • 34. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323-329.ArticlePubMedPMC
  • 35. Liang W, Chikritzhs T. Reduction in alcohol consumption and health status. Addiction 2011;106:75-81.ArticlePubMed
  • 36. Alfano CM, Klesges RC, Murray DM, Bowen DJ, McTiernan A, Vander Weg MW, et al. Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers. Cancer Epidemiol Biomarkers Prev 2004;13:2233-2241.ArticlePubMedPDF
  • 37. Wang A, Qin F, Hedlin H, Desai M, Chlebowski R, Gomez S, et al. Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: the women’s health initiative. Int J Cancer 2016;139:2178-2192.ArticlePubMedPMCPDF
  • 38. Lee IM, Sesso HD, Paffenbarger RS Jr. Physical activity and risk of lung cancer. Int J Epidemiol 1999;28:620-625.ArticlePubMed
  • 39. Pedersen BK, Ullum H. NK cell response to physical activity: possible mechanisms of action. Med Sci Sports Exerc 1994;26:140-146.ArticlePubMed
  • 40. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-1203.ArticlePubMed
  • 41. Yu D, Zheng W, Johansson M, Lan Q, Park Y, White E, et al. Overall and central obesity and risk of lung cancer: a pooled analysis. J Natl Cancer Inst 2018;110:831-842.ArticlePubMedPMC
  • 42. Yang Y, Dong J, Sun K, Zhao L, Zhao F, Wang L, et al. Obesity and incidence of lung cancer: a meta-analysis. Int J Cancer 2013;132:1162-1169.ArticlePubMed
  • 43. Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992;13:2241-2247.ArticlePubMed
  • 44. Mizoue T, Kasai H, Kubo T, Tokunaga S. Leanness, smoking, and enhanced oxidative DNA damage. Cancer Epidemiol Biomarkers Prev 2006;15:582-585.ArticlePubMedPDF
  • 45. Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, et al. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol 2009;38:971-975.ArticlePubMedPMC
  • 46. Kim WY, Jin Q, Oh SH, Kim ES, Yang YJ, Lee DH, et al. Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development. Cancer Res 2009;69:7439-7448.ArticlePubMedPMCPDF
  • 47. Mendonça FM, de Sousa FR, Barbosa AL, Martins SC, Araújo RL, Soares R, et al. Metabolic syndrome and risk of cancer: which link? Metabolism 2015;64:182-189.ArticlePubMed
  • 48. Lindgren A, Pukkala E, Nissinen A, Tuomilehto J. Blood pressure, smoking, and the incidence of lung cancer in hypertensive men in North Karelia, Finland. Am J Epidemiol 2003;158:442-447.ArticlePubMed
  • 49. Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol 2011;12:65-82.ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Comprehensive characterization of early-onset lung cancer, in Chinese young adults
      Ye Tian, Rui Ma, Wenchang Zhao, Shumin Wang, Chuanjiang Zhou, Weibing Wu, Bo Yang, Hua Xin, Hongyan Wang, Pengfei Li, Ranhua Li, Changhong Liu, Yao Lu, Qian Yu, Chengyang Song, Han Zhang, Ruipu Liang, Lei Zhang, Di Zhou, Xitong Zhao, Zhuo Wu, Yafei Qi, Ru
      Nature Communications.2025;[Epub]     CrossRef

    Figure
    • 0
    Risk factors for early-onset lung cancer in Korea: analysis of a nationally representative population-based cohort
    Image
    Figure 1 Flow diagram of study participants.

    Figure 1

    Risk factors for early-onset lung cancer in Korea: analysis of a nationally representative population-based cohort
    Characteristics Early-onset lung cancer incidence
    		 p-value1
    Yes (n=4,684) No (n=6,789,603)
    Age, mean±SD (yr) 33.6±4.5 30.8±5.0 <0.001
     20-29 964 (20.6) 2,891,243 (42.6) <0.001
     30-39 3,720 (79.4) 3,898,360 (57.4)
    Sex <0.001
     Male 2,611 (55.7) 4,075,033 (60.0)
     Female 2,073 (44.3) 2,714,570 (40.0)
    Income <0.001
     Q1 (highest) 1,031 (22.0) 1,688,522 (24.9)
     Q2 1,188 (25.4) 2,096,156 (30.9)
     Q3 1,482 (31.6) 2,003,758 (29.5)
     Q4 (lowest) 983 (21.0) 1,001,167 (14.8)
    Smoking status (pack-yr) <0.001
     Non-smoker 2,585 (55.2) 3,716,798 (54.7)
     Former smoker with <10 492 (10.5) 700,679 (10.3)
     Former smoker with ≥10 183 (3.91) 349,020 (5.1)
     Current smoker with <10 742 (15.8) 1,210,833 (17.8)
     Current smoker with ≥10 682 (14.6) 812,273 (12.0)
    Alcohol consumption (g/day) <0.001
     Non-drinker 1,962 (41.9) 2,562,059 (37.7)
     <10.0 1,351 (28.8) 2,155,232 (31.7)
     10.0-19.9 636 (13.6) 991,387 (14.6)
     20.0-29.9 327 (7.0) 487,563 (7.2)
     ≥30.0 408 (8.7) 593,362 (8.7)
    Physical activity (MET-min/wk) <0.001
     Non-exerciser 1,049 (22.4) 1,382,689 (20.4)
     <500 1,820 (38.9) 2,529,402 (37.3)
     500-999 1,324 (28.3) 2,032,503 (28.0)
     1,000-1,499 367 (7.8) 614,699 (9.1)
     ≥1,500 124 (2.7) 230,310 (3.4)
    BMI (kg/m2) 0.222
     <18.5 329 (7.0) 505,714 (7.5)
     18.5-22.9 2,181 (46.6) 3,164,194 (46.6)
     23.0-24.9 958 (20.5) 1,317,337 (19.4)
     ≥25.0 1,216 (26.0) 1,802,358 (26.6)
    Diabetes 121 (2.6) 128,949 (1.9) <0.001
    Hypertension 426 (9.1) 502,257 (7.4) <0.001
    Dyslipidemia 391 (8.4) 459,750 (6.8) <0.001
    Metabolic syndrome 604 (12.9) 717,332 (10.6) <0.001
    Variables n Event (n) Duration (PY) Incidence rate (per 100,000 PY) Univariable Model 11 Model 22
    Age
     Per 1 yr - - - - 1.13 (1.12, 1.13) 1.13 (1.12, 1.14) 1.13 (1.12, 1.14)
    Sex
     Male 4,077,644 2,611 38,427,542.6 6.78 1.00 (reference) 1.00 (reference) 1.00 (reference)
     Female 2,716,643 2,073 25,134,725.4 8.25 1.23 (1.16, 1.31) 1.58 (1.46, 1.72) 1.62 (1.49, 1.75)
    Income
     Q1 (highest) 1,689,553 1,031 15,536,470.2 6.64 0.66 (0.61, 0.72) 0.86 (0.78, 0.94) 0.86 (0.78, 0.94)
     Q2 2,097,344 1,188 19,459,692.7 6.11 0.61 (0.56, 0.66) 0.85 (0.78, 0.93) 0.85 (0.78, 0.93)
     Q3 2,005,240 1,482 18,998,286.8 7.80 0.76 (0.70, 0.83) 0.92 (0.85, 1.00) 0.92 (0.85, 1.00)
     Q4 (lowest) 1,002,150 983 9,567,818.3 10.27 1.00 (reference) 1.00 (reference) 1.00 (reference)
    Smoking status (pack-yr)
     Non-smoker 3,719,383 2,585 34,596,750.0 7.47 1.00 (reference) 1.00 (reference) 1.00 (reference)
     Former smoker with <10 701,171 492 6,657,102.4 7.39 0.97 (0.88, 1.07) 1.01 (0.91, 1.13) 1.01 (0.91, 1.13)
     Former smoker with ≥10 349,203 183 3,243,215.8 5.64 0.76 (0.65, 0.88) 0.95 (0.81, 1.11) 0.95 (0.81, 1.11)
     Current smoker with <10 1,211,575 742 11,376,708.6 6.52 0.87 (0.80, 0.94) 1.12 (1.01, 1.24) 1.12 (1.01, 1.24)
     Current smoker with ≥10 812,955 682 7,688,491.1 8.87 1.17 (1.08, 1.27) 1.30 (1.18, 1.45) 1.29 (1.16, 1.44)
    Alcohol consumption (g/day)
     Non-drinker 2,564,021 1,962 23,927,308.5 8.20 1.00 (reference) 1.00 (reference) 1.00 (reference)
     <10.0 2,156,583 1,351 20,129,448.0 6.71 0.82 (0.76, 0.88) 0.92 (0.86, 0.99) 0.93 (0.86, 0.99)
     10.0-19.9 992,023 636 9,339,152.5 6.81 0.83 (0.75, 0.90) 0.95 (0.87, 1.05) 0.95 (0.87, 1.05)
     20.0-29.9 487,890 327 4,592,433.7 7.12 0.86 (0.77, 0.97) 0.96 (0.85, 1.09) 0.96 (0.85, 1.09)
     ≥30.0 593,770 408 5,573,925.3 7.32 0.89 (0.80, 0.99) 1.01 (0.90, 1.13) 1.00 (0.89, 1.13)
    Physical activity (MET-min/wk)
     Non-exerciser 1,383,738 1,049 12,881,555.6 8.14 1.00 (reference) 1.00 (reference) 1.00 (reference)
     <500 2,531,222 1,820 23,740,196.2 7.67 0.94 (0.87, 1.00) 0.97 (0.90, 1.04) 0.97 (0.90, 1.04)
     500-999 2,033,827 1,324 19,014,025.4 6.96 0.85 (0.79, 0.92) 0.95 (0.88, 1.04) 0.95 (0.88, 1.03)
     1,000-1,499 615,066 367 5,767,558.8 6.36 0.78 (0.69, 0.88) 0.88 (0.78, 0.99) 0.88 (0.78, 0.99)
     ≥1,500 230,434 124 2,158,931.9 5.74 0.70 (0.58, 0.85) 0.83 (0.69, 0.99) 0.82 (0.68, 0.99)
    BMI (kg/m2)
     <18.5 506,043 329 4,696,833.9 7.01 0.95 (0.85, 1.07) 1.07 (0.95, 1.20) 1.07 (0.95, 1.20)
     18.5-22.9 3,166,375 2,181 29,568,682.4 7.38 1.00 (reference) 1.00 (reference) 1.00 (reference)
     23.0-24.9 1,318,295 958 12,394,350.4 7.73 1.04 (0.97, 1.13) 1.00 (0.92, 1.08) 1.00 (0.92, 1.08)
     ≥25.0 1,803,574 1,216 16,902,391.0 7.19 0.97 (0.91, 1.04) 0.89 (0.83, 0.96) 0.88 (0.81, 0.95)
    Diabetes
     No 6,291,604 4,563 62,354,799.9 7.32 1.00 (reference) 1.00 (reference) -
     Yes 502,683 121 1,207,468.1 10.02 1.37 (1.14, 1.64) 1.08 (0.90, 1.30) -
    Hypertension
     No 6,334,146 4,258 58,837,673.6 7.24 1.00 (reference) 1.00 (reference) -
     Yes 460,141 426 4,724,594.4 9.02 1.24 (1.12, 1.37) 1.10 (0.99, 1.22) -
    Dyslipidemia
     No 6,076,351 4,293 59,230,914.6 7.25 1.00 (reference) 1.00 (reference) -
     Yes 717,936 391 4,331,353.4 9.03 1.24 (1.12, 1.37) 1.05 (0.94, 1.17) -
    Metabolic syndrome
     No 4,077,644 4,080 56,810,731.3 7.18 1.00 (reference) - 1.00 (reference)
     Yes 2,716,643 604 6,751,536.7 8.95 1.24 (1.14, 1.35) - 1.13 (1.03, 1.24)
    Variables N Age (yr)
    		 Sex
    Event (n) 20-29 Event (n) 30-39 pinteraction Event (n) Male Event (n) Female pinteraction
    Age
     Per 1 yr 1.13 (1.12, 1.14) 1.12 (1.11, 1.13) 0.204
    Sex
     Male 4,077,644 398 1.00 (reference) 2,213 1.00 (reference) 0.047 - -
     Female 2,716,643 566 1.83 (1.53, 2.17) 1,507 1.49 (1.36, 1.64) - -
    Income 0.817 0.070
     Q1 (highest) 1,689,553 260 0.84 (0.66, 1.08) 771 0.87 (0.79, 0.96) 365 0.76 (0.67, 0.87) 666 1.00 (0.87, 1.16)
     Q2 2,097,344 359 0.82 (0.65, 1.05) 829 0.86 (0.78, 0.95) 601 0.81 (0.73, 0.91) 587 0.94 (0.82, 1.09)
     Q3 2,005,240 265 0.95 (0.73, 1.21) 1,217 0.91 (0.83, 0.99) 931 0.88 (0.80, 0.98) 551 1.01 (0.87, 1.17)
     Q4 (lowest) 1,002,150 80 1.00 (reference) 903 1.00 (reference) 714 1.00 (reference) 269 1.00 (reference)
    Smoking status (pack-yr) 0.124 0.530
     Non-smoker 3,719,383 633 1.00 (reference) 1,952 1.00 (reference) 682 1.00 (reference) 1,903 1.00 (reference)
     Former smoker with <10 701,171 77 1.36 (1.06, 1.75) 415 0.95 (0.85, 1.08) 424 1.00 (0.88, 1.13) 68 1.07 (0.84, 1.37)
     Former smoker with ≥10 349,203 43 0.99 (0.72, 1.37) 140 0.93 (0.78, 1.11) 137 0.97 (0.81, 1.17) 46 0.89 (0.66, 1.20)
     Current smoker with <10 1,211,575 143 1.19 (0.95, 1.48) 599 1.10 (0.98, 1.23) 691 1.11 (1.00, 1.24) 51 1.33 (0.99, 1.76)
     Current smoker with ≥10 812,955 68 1.23 (0.92, 1.64) 614 1.29 (1.15, 1.44) 677 1.30 (1.16, 1.45) 5 0.80 (0.33, 1.92)
    Alcohol consumption (g/day) 0.088 0.011
     Non-drinker 2,564,021 382 1.00 (reference) 1,580 1.00 (reference) 735 1.00 (reference) 1,227 1.00 (reference)
     <10.0 2,156,583 333 0.99 (0.85, 1.15) 1,018 0.90 (0.83, 0.98) 706 0.82 (0.74, 0.91) 645 1.02 (0.92, 1.12)
     10.0-19.9 992,023 113 0.86 (0.69, 1.07) 523 0.97 (0.87, 1.08) 500 0.87 (0.77, 0.98) 136 1.08 (0.90, 1.30)
     20.0-29.9 487,890 71 1.20 (0.92, 1.56) 256 0.91 (0.79, 1.05) 294 0.92 (0.80, 1.06) 33 0.79 (0.56, 1.12)
     ≥30.0 593,770 65 0.89 (0.67, 1.18) 343 1.03 (0.90, 1.17) 376 0.96 (0.84, 1.09) 32 0.90 (0.62, 1.28)
    Physical activity (MET-min/wk) 0.763 0.147
     Non-exerciser 1,383,738 183 1.00 (reference) 866 1.00 (reference) 506 1.00 (reference) 543 1.00 (reference)
     <500 2,531,222 369 1.01 (0.84, 1.20) 1,451 0.96 (0.88, 1.04) 965 1.03 (0.92, 1.14) 855 0.91 (0.82, 1.02)
     500-999 2,033,827 298 0.98 (0.81, 1.18) 1,026 0.95 (0.87, 1.04) 804 1.03 (0.92, 1.15) 520 0.88 (0.78, 0.99)
     1,000-1,499 615,066 89 1.03 (0.80, 1.33) 278 0.85 (0.74, 0.97) 252 0.98 (0.84, 1.14) 115 0.76 (0.62, 0.93)
     ≥1,500 230,434 25 0.81 (0.54, 1.24) 99 0.83 (0.68, 1.03) 84 0.83 (0.66, 1.05) 40 0.88 (0.64, 1.22)
    BMI (kg/m2) 0.312 <0.001
     <18.5 506,043 112 0.93 (0.76, 1.14) 217 1.13 (0.98, 1.31) 84 1.45 (1.16, 1.81) 245 0.97 (0.84, 1.11)
     18.5-22.9 3,166,375 538 1.00 (reference) 1,643 1.00 (reference) 907 1.00 (reference) 1,274 1.00 (reference)
     23.0-24.9 1,318,295 161 1.06 (0.88, 1.27) 797 0.99 (0.90, 1.08) 644 0.93 (0.84, 1.03) 314 1.14 (1.01, 1.30)
     ≥25.0 1,803,574 153 0.87 (0.72, 1.05) 1,063 0.90 (0.83, 0.98) 976 0.88 (0.80, 0.97) 240 0.89 (0.77, 1.02)
    Diabetes 0.235 0.067
     No 6,291,604 959 1.00 (reference) 3,604 1.00 (reference) 2,507 1.00 (reference) 2,056 1.00 (reference)
     Yes 502,683 5 0.64 (0.27, 1.54) 116 1.10 (0.91, 1.33) 104 1.17 (0.96, 1.43) 17 0.72 (0.45, 1.17)
    Hypertension 0.196 0.064
     No 6,334,146 932 1.00 (reference) 3,326 1.00 (reference) 2,242 1.00 (reference) 2,016 1.00 (reference)
     Yes 460,141 32 0.88 (0.61, 1.26) 394 1.12 (1.01, 1.25) 369 1.15 (1.02, 1.29) 57 0.88 (0.67, 1.17)
    Dyslipidemia 0.923 0.787
     No 6,076,351 928 1.00 (reference) 3,365 1.00 (reference) 2,309 1.00 (reference) 1,984 1.00 (reference)
     Yes 717,936 36 1.04 (0.74, 1.45) 355 1.05 (0.94, 1.17) 302 1.06 (0.94, 1.20) 89 1.03 (0.83, 1.27)
    Table 1. Baseline characteristics of study participants

    Values are presented as number (%).

    SD, standard deviation; Q, quartile; MET, metabolic equivalents of task; BMI, body mass index.

    Categorical variables were compared using the chi-square test, and continuous variables were compared using the Student t-test.

    Table 2. Risk of lung cancer in young adults

    Values are presented as hazard ratio (95% confidence interval).

    PY, person-years; Q, quartile; MET, metabolic equivalents of task; BMI, body mass index.

    Model 1 was adjusted for age, sex, income, smoking status, alcohol consumption, physical activity, obesity, diabetes, hypertension, and dyslipidemia.

    Model 2 was adjusted for age, sex, income, smoking status, alcohol consumption, physical activity, and metabolic syndrome.

    Table 3. Stratification of lung cancer risk by age and sex in young adults1

    Values are presented as hazard ratio (95% confidence interval).

    Q, quartile; MET, metabolic equivalents of task; BMI, body mass index.

    The stratified analysis was adjusted for age, sex, income, smoking status, alcohol consumption, physical activity, obesity, diabetes, hypertension, and dyslipidemia.

    Table 1.

    Table 2.

    Table 3.

    Epidemiol Health : Epidemiology and Health
    © Korean Society of Epidemiology.
    TOP